Skip to main content
. 2016 Apr 25;36(4):335–341. doi: 10.3343/alm.2016.36.4.335

Table 2. Annual reported cases of suspected adverse reactions investigated by the recipient-triggered trace back in Korea, 2006-2014.

Category N of annual reported cases Total (%)
2006 2007 2008 2009 2010 2011 2012 2013 2014
HCV infection 42 25 10 15 13 8 11 6 5 135 (67.8)
HBV infection 5 0 2 2 3 2 4 6 3 27 (13.6)
HIV infection 4 1 2 3 1 0 1 0 1 13 (6.5)
Syphilis infection 1 1 2 3 0 0 1 0 1 9 (4.5)
Malarial infection* 1 2 1 0 0 0 0 0 0 4 (2.0)
Bacterial infection 0 0 0 1 0 1 0 1 0 3 (1.5)
HTLV infection 0 0 0 0 1 0 0 0 0 1 (0.5)
Scrub typhus infection 0 0 0 0 0 0 0 0 1 1 (0.5)
TRALI 0 0 0 1 1 0 0 1 0 3 (1.5)
AHR 0 0 0 1 0 0 0 0 0 1 (0.5)
Seizure 0 0 1 0 0 0 0 0 0 1 (0.5)
ARDS 0 0 0 1 0 0 0 0 0 1 (0.5)
Subtotal 53 29 18 27 19 11 17 14 11 199 (100.0)

*Three cases of malaria were reported each year from 2006 to 2008 by Kim et al. [2].

Abbreviations: AHR, acute hemolytic transfusion reaction; ARDS, acute respiratory distress syndrome; HBV, hepatitis B virus; HCV, hepatitis C virus; HTLV, human T cell leukemia virus; TRALI, transfusion-related acute lung injury.